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Abstract
Rational Prefrontal cortical (PFC)–hippocampal–striatal cir-
cuits, interconnected via glutamatergic signaling, are dysfunc-
tional in mental illnesses that involve addiction vulnerability.
Objectives In healthy and neurodevelopmentally altered rats,
we examined how Radial Arm Maze (RAM) performance
estimates addiction vulnerability, and how starting a gluta-
matergic modulating agent, N-acetyl cysteine (NAC) in ado-
lescence alters adult mental illness and/or addiction
phenotypes.
Methods Rats with neonatal ventral hippocampal lesions
(NVHL) vs. SHAM-operated controls were randomized to
NAC vs. saline in adolescence followed by cognitive testing
(RAM) in early adulthood and then cocaine behavioral sensi-
tization (experiment 1; n = 80) or nicotine self-administration
(experiment 2; n = 12).
Results In experiment 1, NVHL rats showed over-
consumption of food (Froot-Loops (FL)) baiting the RAM
with poor working memory (low-arm entries to repeat
(ETR)), producing an elevated FL to ETR ratio (BFLETR^;
p < 0.001). FLETR was the best linear estimator (compared to
FL or ETR) of magnitude of long-term cocaine sensitization
(R2 = 0.14, p < 0.001). NAC treatment did not alter FL, ETR,
FLETR, or cocaine sensitization. In experiment 2, FLETR
also significantly and uniquely correlated with subsequent
drug seeking during nicotine-induced reinstatement after ex-
tinction of nicotine self-administration (R2 = 0.47, p < 0.01).
NAC did not alter RAM performance, but significantly re-
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versed NVHL-induced increases in nicotine seeking during
extinction and reinstatement.
Conclusions These findings demonstrate the utility of animal
models of mental illness with addiction vulnerability for de-
veloping novel diagnostic measures of PFC–hippocampal–
striatal circuit dysfunction that may reflect addiction risk.
Such tests may direct pharmacological treatments prior to
adulthood and addictive drug exposure, to prevent or treat
adult addictions.
Keywords Schizophrenia . Neurodevelopment . Dual
diagnosis . Radial armmaze . Cocaine . Behavioral
sensitization . N-acetyl cysteine . Adolescence
Introduction
Substance use disorders are concentrated in mentally ill peo-
ple (Regier et al. 1990) producing greater psychiatric and
medical morbidity, risk of incarceration, homelessness, and
early death (Drake et al. 2001; Owen et al. 1996). Preclinical
models show that dysfunctional cortical–striatal–temporal–
limbic circuitry like that in mental illness enhances drug-
reinforcement and addiction vulnerability (Chambers et al.
2001, 2010a). Specifically, early ventral hippocampus damage
in rats, resulting in abnormal connectivity and functionality of
the prefrontal cortex (PFC) and nucleus accumbens, generates
adult psychiatric symptoms while lowering thresholds for ac-
quiring addiction (Chambers 2007; Chambers et al. 2007;
Chambers and Self 2002). Meanwhile, longitudinal human
studies show that heritable, childhood Bexternalizing^ pheno-
types lead to both adult mental illness and substance disorders
(Iacono et al. 2008; Malone et al. 2002; Tarter et al. 2003;
Zucker 2008).
Glutamate neurotransmission mediates communication be-
tween the ventral hippocampus, PFC, and nucleus accumbens
(Kelley and Domesick 1982; O’Donnell et al. 1999; Pennartz
et al. 1994). Dopamine-facilitated plasticity at glutamate syn-
apses in the nucleus accumbens invokes healthy and patho-
logical changes in motivated behavior (Chambers et al. 2007;
Goto and Grace 2005; Grace et al. 2007; Kauer and Malenka
2007). Accordingly, dysfunction of cortical–striatal circuits
that utilize glutamate may underpin mental illness (Adler
et al. 1999; Goff and Coyle 2001; Jentsch and Roth 1999),
addiction (Kalivas 2009; Rao et al. 2015), and their linkage
(Chambers et al. 2001, 2007). In testing this theory, we exam-
ined radial arm maze (RAM) measures of PFC–hippocampal-
dependent cognition (Floresco et al. 1997), and the effects of
N-acetyl cysteine (NAC), a glutamate-modulating agent
(Baker et al. 2002) on addiction-related behaviors in neonatal
ventral hippocampal lesion (NVHL) rats.
The NVHL model of schizophrenia (Lipska et al. 1993) is
produced by delivering ibotenic acid to the ventral
hippocampus of 7-day old rats, approximating the third tri-
mester of human development (Clancy et al. 2007). NVHL
rats show peri-adolescent onset of positive-like symptoms as-
sociated with schizophrenia and Bexternalizing^ disorders, in-
cluding behavioral hyperactivity to stress and novelty that is
treatable with neuroleptics (Lipska and Weinberger 1994).
They also show prodromal social deficits (Sams-Dodd et al.
1997) and cognitive impairment reflecting PFC–hippocampal
network dysfunction that is refractory to neuroleptics (Bahner
et al. 2015; Brady et al. 2010; Chambers et al. 1996; Tek et al.
2002). Molecular, cellular, and functional abnormalities relat-
ed to PFC glutamate neurotransmission in NVHL rats parallel
neuroimaging and histopathological findings in schizophrenia
(Chambers et al. 2013; Tseng et al. 2009). Replicating extreme
rates of addiction in schizophrenia (Barnett et al. 2007;
Volkow 2009), NVHL rats are abnormally sensitive to the
activating and reinforcing effects of cocaine, nicotine, and
alcohol (Berg and Chambers 2008; Berg et al. 2011, 2014;
Chambers and Self 2002; Chambers and Taylor 2004;
Conroy et al. 2007).
Using NVHL and SHAM-operated rats, we conducted two
developmental–longitudinal experiments that started N-
acetyl-cysteine (NAC) treatment in adolescence, and mea-
sured adult RAM-cognitive performance profiles before be-
havioral sensitization to cocaine (experiment 1), or nicotine
self-administration (experiment 2). NAC is a pro-drug for glu-
tathione, which protects neurons from cumulative oxidative
stress, and cysteine, which, via glial cysteine/glutamate trans-
porters, raises extra-synaptic levels of glutamate (Asevedo
et al. 2014; Cabungcal et al. 2014; Lavoie et al. 2008;
Moran et al. 2005). This mechanism increases glutamatergic
tone onto cortical-striatal axonal terminals that bear metabo-
tropic glutamate receptors (mGluR2/3), which dampens
stimulus-induced glutamate release, e.g., corresponding to
drug-related cues, and craving, or glutamate dysregulation in
mental illness (Carmeli et al. 2012; Knackstedt et al. 2010;
Kupchik et al. 2012; Moussawi et al. 2009). Interposing
RAM-testing between adolescent NAC treatment initiation
and adult addiction-related behavioral phenotyping allowed
testing of potential effects of NAC on RAM performance,
and exploration of how RAM performance could estimate
severity of subsequent addiction-related behavior.
Materials and methods
Subjects, neonatal surgery, drugs, and experimental
design
Pregnant Sprague-Dawley rats (Harlan, Indianapolis) arriving
at 14- to 16-days gestation, were housed on a 12-h light cycle.
Male pups (15–18 g; PD 7) received ibotenate (3 μg) or vehi-
cle (0.3 μl) into the ventral hippocampus bilaterally (AP −3.0,
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ML ±3.5, VD −5.0 mm/bregma), detailed in (Chambers and
Lipska 2011). Pups were returned to litters balanced closely to
5:4 ratios of lesioned to SHAMs. After weaning (PD 21), pups
were pair-housed (same lesion) then singly housed at the be-
ginning of RAM (PD 55–63). Different rats were prepared for
experiments 1 and 2. Animal care complied with theGuide for
the Care and Use of Laboratory Animals, and Indiana
University IACUC.
NAC (Sigma, St. Louis, MO, USA) was prepared in
saline, NaOH adjusted to pH 7.2 at 100 mg/ml (shown
to modulate cocaine-seeking in rats (Reichel et al. 2011)).
Rats were randomized to daily NAC (100 mg/kg ip) or
saline (SAL; 1 ml/kg) injections, 60–90 min before be-
havioral testing. For experiment 1 (Fig. 1a), Cocaine
(NIDA) was prepared in stock (15 mg/ml) and injected
at 15 mg/kg ip. For experiment 2 (Fig. 1b), d-
amphetamine sulfate (Sigma) was injected at 1.5 mg/kg
ip (Lipska et al. 1993). Nicotine hydrogen tartrate salt
(Sigma) was prepared in 0.9 % sterile saline to make a
0.5 mg/ml stock (base of the salt, pH adjusted to 7.4
(Matta et al. 2007)). Self-administration concentrations
were prepared per rat weight from stock as were the 0.5
or 0.25 mg/kg of nicotine for reinstatement. In experiment
1, ra ts began dai ly inject ions on PD 28 (ear ly
adolescence; Bell et al. 2014). About twice as many rats
entered NAC compared to SAL treatment so that the NAC
group could be further randomized (PD 56) to saline
(NAC-SAL), or NAC continuation ((NAC-NAC) through
RAM (PD 56–74) until the end of initial cocaine sensiti-
zation (PD 81–85). In experiment 2 (Fig. 1b), NAC or
SAL began in mid-adolescence (PD 42), and continued
through locomotor testing, RAM, and nicotine self-
administration (PD 91–122).
Radial arm maze (experiments 1 and 2)
One day before and during RAM, rats were food restricted to
support reward seeking. Rat chow (Harlan; 1–2 bricks (5 g))
was delivered to home cages after sessions to maintain body
weights at 15% from pre-RAMweights. The RAM, described
in detail in (Berg et al. 2015), had eight 10 × 60-cm runways
extending radially from a central arena (50-cm diameter). For
each session, a receptacle at the end of all 8 arms was pre-
loaded with 1/2 of a Kellogg’s Froot Loop®. After starting
from the central arena, rats explored the maze until either all
arms were entered (four paws in) or 300-s elapsed. The inves-
tigator, blind to group, recorded three dependent measures: (1)
entries to repeat (ETR), number of arms entered without a
repeat (measure of working memory); (2) session time, total
time to enter all arms (measure of performance efficiency);
and (3) total number of Froot Loops (FL) consumed (measure
of appetitive motivation). FL ranged from 0 to 8, never
exceeded arms entered, but could be greater or less than ETR.
Cocaine sensitization (experiment 1) and locomotor
activation (experiment 2)
Locomotor recording was measured in 43.2 × 43.2 × 30.5-cm
arenas equipped with infrared beams (Med Associates, de-
scribed in (Chambers and Taylor 2004). Initial cocaine sensi-
tization was assessed in 2-h, daily sessions for 5 days, with
cocaine delivered after 1 h, and a challenge session 2 weeks
later. Experiment 2 rats were tested in a single 3-h session for
measuring locomotion to the novel environment (hour 1), a
saline injection (1 ml/kg ip @ 60 min) and amphetamine
(1.5 mg/kg ip @120 min).
Fig. 1 Experimental schedule for
experiments 1 (a) and 2 (b).
Postnatal Day (PD) timing of ex-
perimental interventions and N-
acetyl cysteine (NAC) dosing ac-
cording to treatment groups and
numbers of animals per subgroup
(n) are shown
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Nicotine self-administration (experiment 2)
After a week of recovery from jugular catheter implanta-
tion (see (Berg et al. 2014)) rats were food restricted for
15 sessions of acquisition of nicotine self-administration
(two-lever Med Associates chambers detailed previously
(Berg et al. 2014)). Two-hour sessions started with house
lights on to signal drug availability with a single priming
infusion of nicotine. Responses on the nicotine-paired le-
ver turned house lights off and a cue light above the
nicotine lever on for the 3-s infusion (0.015 mg/kg nico-
tine in 0.050 ml saline (FR1)). A 17-s time out began after
infusion when presses had no effects and all lights were
out. After acquisition and 2 days off, rats entered 5 days
of 2-h extinction sessions when catheters were not con-
nected, and lever presses produced no infusions. After
extinction and 2-days off, rats underwent 3-days of 2-h
reinstatement sessions (catheters not connected) in which
rats were given injections, 30 min before, of saline (day 1,
1 mg/kg ip), and nicotine (day 2, 0.25 mg/kg ip; day 3,
0.5 mg /kg).
Data analysis and lesion verification
For experiment 1, initial analyses utilized omnibus two-
way repeated measure ANOVAs (independent factors of
lesion (NVHL vs. SHAM) and drug (three levels: SAL,
NAC-SAL, NAC-NAC)). For RAM, dependent measures
(ETR, session time, FL) were across bins (means of three
consecutive daily sessions). For cocaine sensitization, day
1 and challenge data were examined as a repeated mea-
sure of pre- vs. post-injection locomotion, while sensiti-
zation over the 5-days examined post-injection activity.
Post hoc testing examined interactions between main ef-
fects or main effects and time, with unitary ANOVAs and
Bonferroni corrections as appropriate. In experiment 2,
similar two-way, repeated measure ANOVAs examined
lesion and drug (SAL vs. NAC). In the locomotor session,
the hour was the repeated measure whereas in RAM and
nicotine self-administration, bins and days were repeated.
All significant (p < 0.05) results (and important p > 0.05,
NS, findings) are reported with data presented as
means ± SEM. Linear regressions examined relationships
between RAM and cocaine sensitization or nicotine self-
administration. Only rats with brains revealing accurate
lesions by pre-established criteria, assessed blind to be-
havioral results (detailed in (Chambers and Lipska
2011)) were analyzed. In experiment 1, 8 of 48 brains,
and in experiment 2, 2 of 8 had disqualifying lesions
and were excluded. Figure 2 shows mapping of lesions
among NVHL rats (n = 40 in experiment 1; n = 6 in
experiment 2) included in the study.
Results
Experiment 1: RAM and cocaine behavioral sensitization
One day prior to RAM (∼PD 56), NVHL rats (n = 40) weighed
278.7 ± 2.8 g, compared to SHAMS (n = 40; 286.9 ± 2.9 g). This
3 % difference was significant (lesion: F(1,74) = 4.3, p < 0.05),
while NAC had no effect, or interaction with NVHLs on weight.
Rats showed learning on the RAM with increasing ETR over
sessions (bins: F(5, 370) = 49.0, p < 0.001; Fig. 3a). However,
NVHLs were impaired with lower ETR (lesion: F(1, 74) = 44.4,
p < 0.001) and deficient ETR across sessions (lesion × bins: F(5,
370) =5.4, p < 0.001). NAC treatment had no effect or interac-
tions in altering ETR. For session time (Fig. 3b), overall improve-
ment in maze performance occurred (bins: F(5370) = 205,
p < 0.001), but NVHLs were slower (NVHL vs. SHAM com-
parison: Fig. 3b, left; lesion: F(1,74) = 25.5, p < 0.001).
However, NVHLs did show improvement at rates that were
not different from SHAMs (lesion × bins: F(5,370) = 2.1, NS).
NAC treatment did show a significant main effect in altering
session time (drug: F(2,74) = 3.4, p < 0.05) without interactions.
NACdosing group comparisons are shown in Fig. 3b, right. Rats
treated with saline tended to be more efficient in completing the
maze (mean session time/bin, 182.9 + 5.5 s) compared to their
NAC-SAL (188.9 + 6.5 s) and NAC-NAC (201.0 + 4.7 s) coun-
terparts, although post-hoc analyses (one-way ANOVA/
Bonferroni) did not tease out a significant difference between
any two regimens. Across bins, there were overall increases in
FL eating (bins: F(5370) = 259.4, p < 0.001; Fig. 3c). Notably,
despite NVHL deficits in cognitive performance, NVHL rats
showed greater FL consumption (lesion: F(1,74) = 15.4,
p < 0.001), particularly in the earlier bins (lesion × bins:
F(5370) = 5.2, p < 0.001). NAC did not impact FL consumption.
In behavioral sensitization, cocaine increased locomotion
on day 1 (Fig. 4a; hour: F(1,74) = 14, p < 0.001). There was an
effect of NVHL to increase locomotion generally (lesion:
F(1,74) = 8.2, p < 0.01), but without a lesion × hour interac-
tion. Figure 4a, left, shows lesion group comparisons; Fig. 4a,
right, shows NAC group comparisons. NAC did impact co-
caine’s stimulating locomotor response (drug × hour:
F(2,74) = 4.1, p < 0.05), but NAC had no effect or interactions
with NVHL. This effect was further observed in post hoc
testing (one way ANOVAs of drug regimen on pre-injection
and post-injection locomotion separately). There were no dif-
ferences in pre-injection locomotion by NAC regimen, but
post-injection, the three groups differed significantly
(F(2,77) = 3.5, p < 0.05), with NAC-SAL and NAC-NAC
groups showing the lowest vs. highest post-injection locomo-
tion respectively (Bonferroni, p < 0.05). Figure 4b shows co-
caine sensitization over the 5 days. There was a significant
behavioral sensitization effect (day: F(4296) = 7.6,
p < 0.001). Again, NVHL rats showed increased cocaine-
induced activation throughout the series (lesion:
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F(1,74) = 18.8, p < 0.001 with lesion × day: F(4296) = 0.7,
p = NS), while NAC regimen had no main effect or interac-
tions. In the cocaine challenge session, cocaine increased lo-
comotion (hour: F(1,74) = 110.9, p < 0.001; Fig. 4c). NVHLs
showed overall increased locomotion (lesion: F(1,74) = 13.8,
p < 0.001), and greater cocaine-induced increases (le-
sion × hour: F(1,74) = 7.5, p < 0.01). NAC history produced
no main effect or interactions.
RAMperformance as an estimator of cocaine sensitization
For all N = 80 rats, we calculated mean ETR, mean FL
consumed, and ratio of mean FL to mean ETR
(BFLETR^), over the 18 RAM sessions (Table 1, left).
Mean FL and mean ETR were not linearly associated
(R2 = 0.002, p = NS) with each other. As already de-
scribed, ETR, and FL were not altered by NAC, and we
further confirmed that mean FLETR was also not altered
by NAC as a main effect or interaction. In contrast, the
effect of lesion on mean FLETR was significant
(F(1,74) = 48, p < 0.001). Also, simple t tests showed
that NVHLs were significantly different from SHAMs
across FL, ETR and FLETR (p < 0.001), with the largest
difference (% change between SHAMs and NVHLS) oc-
curring with FLETR (+57.3 %), compared to +28.6 %
for FL and −15.8 % for ETR; Table 1, left). Linear re-
gressions performed between each of these RAM vari-
ables and post-injection locomotion across progressive
stages of cocaine sensitization (day 1, day 5, challenge
day) are shown in Table 1, right. FLETR was a better
correlate (highest R2; greater significance) of cocaine ac-
tivation than either FL or ETR alone on any given day of
sensitization, and the correlation of FLETR with post-
cocaine locomotion improved as the number of cocaine
sensitization sessions increased (Fig. 5). Also as
suggested in Fig. 5 plots, variance associated with
FLETR in both SHAM and NVHL groups contributed
to this relationship. Neither NVHL nor SHAM subgroups
taken alone produced significant linear regressions; out-
lier analysis testing the removal of the five SHAM ani-
mals on the leftmost range of the challenge data also did
not change the strength of the linear correlation (N = 75:
R2 = 0.14, p < 0.001).
Experiment 2: locomotor stimulation, RAM and nicotine
self-administration
Rats (n = 12) first tested in a 3-h locomotor activation test
showed significant overall differences in locomotion by time
(hours: F(2, 16) = 12.2, p = 0.001) reflecting different re-
sponses to novelty (hour 1, 10,364 ± 873 cm), saline (hour
2 , 5 ,105 ± 473 cm) , and amphetamine(hour 3 ,
10,094 ± 1,238 cm). However, there were no significant main
effects or interactions of lesion or NAC, although NVHLs
tended to show more amphetamine activation (NVHL,
10,515 ± 2,420 cm vs. SHAM, 9,673 ± 899 cm).
One day prior to RAM, NVHL rats weighed
287.0 ± 4.5 g, compared to SHAMS (299.0 ± 12.3 g).
This 4 % difference was not significant, and NAC had no
effect or interactions on weight. In RAM testing, ETR
showed a significant overall improvement for all rats (bins:
F(4, 32) = 12.8, p < 0.001) going from 3.3 + 0.3 (bin 1) to
5.9 ± 0.4 (bin 5). However, there were no significant main
effects or interactions of NVHL or NAC. Similarly, session
time shortened significantly (bins: F(4, 32) = 31.5,
p < 0.001), going from 278 ± 9.2 s (bin 1) to 165.8 +
17.4 s (bin 5). However, again, there were no significant
NVHL or NAC-based differences or interactions on session
time. Rats also consumed more FL across sessions (bins:
F(4, 32) = 32.1, p < 0.001), going from 0.1 ± 0.04 (bin 1)
Fig. 2 Representative maps and
photomicrographs of rats
included in the study. Left four
panels show greatest (solid black)
and least (white within the black
area) extent of tissue damage in
NVHL rats included in the study
in coronal sections (in millimeter
relative to Bregma; Swanson
2004). The micrographs at right
shows an example of histology of
a NVHL compared to a SHAM
brain where lateral ventricular
enlargement and atrophy of pri-
mary ventral hippocampal cell
layers are observable at low
magnification
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to 5.5 ± 0.8 in (bin 5), without significant effects of lesion,
NAC, or interactions.
In nicotine self-administration, rats showed good acquisi-
tion of responding for nicotine over 15 sessions (day:
F(14,112) = 13.8, p < 0.001; Fig. 6a). This activity was
paralleled by a smaller but still significant growth of
nicotine-paired (active) lever responding that occurred during
the time-out (day: F(14,112) = 3.2, p < 0.001; Fig. 6b). The
inactive (non-nicotine) lever did not elicit significant growth
in responding (day: F(14,112) = 0.8, p = NS; Fig. 6c).
Although NVHLs tended to show greater responding on the
nicotine-paired lever (Fig. 6a, b), these differences were not
significant. NAC also did not impact lever responding and
there were no interactions between NVHLs and NAC on
any acquisition measures. In extinction, overall nicotine-
paired lever pressing declined (day: F(4,32) = 4.8, p < 0.01;
Fig. 7a), but now, NVHL rats showed significant resistance to
extinction (lesion: F(1,8) = 21.7, p < 0.01). This was accom-
panied by an effect of NAC to decrease nicotine-paired lever
pressing (drug: F(1,8) = 23.5, p = 0.001), that was carried by
an action to specifically suppress pressing in NVHL rats to
levels comparable to SHAMs (lesion × drug: F(1,8) = 24,
p = 0.001). On the non-nicotine-paired lever (Fig. 7b), there
was no significant overall change in responding or lesion ef-
fect, or interaction with NAC, although a day × drug interac-
tion was detected (F(4,32) = 4.8, p < 0.01) that is likely spu-
rious given the very low levels of all responding on the inac-
tive lever. In reinstatement, rats showed significant increases
in nicotine-paired lever responding due to nicotine pre-
injections (day: F(2,16) = 5.5, p < 0.05; Fig. 7c). This effect
Fig. 3 Cognitive testing on the
radial arm maze (RAM;
experiment 1). For each
dependent measure: (a entries to
Repeat; b session time; c Froot
Loops consumed)), drug
treatment and lesion status were
analyzed as independent factors
in the same mixed ANOVA,
across the six bins (18 days;
3 days per bin) of testing. Data are
shown primarily according to
lesion grouping only, given that
significant lesion-based differ-
ences were identified across all
three dependent performance
measures. In the left panel of b,
the data is grouped by lesion sta-
tus, whereas on the right, the
same data is grouped according to
drug group only to allow visuali-
zation of the main effect of drug
treatment. Total rats and subgroup
numbers examined are shown in
Fig.1. Data are depicted as
means ± SEMs. All significant
main effects and interactions of
the mixed ANOVA for each de-
pendent variable are shown at
right with significance levels de-
noted as *p < 0.05, ** p < 0.01,
and *** p < 0.001
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was accompanied by overall increases in responding by
NVHL rats (lesion: F(1,8) = 12.2, p < 0.01), and overall
suppression of responding due to NAC (drug: F(1,8) = 13.2,
p < 0.01). NAC specifically suppressed high reinstatement
Fig. 4 Cocaine sensitization
(experiment 1). Data are shown
primarily according to lesion
grouping only, given that
significant lesion-based differ-
ences were identified across all
three stages of behavioral sensiti-
zation. Pre and post-injection lo-
comotor distance (per hour) sur-
rounding the first cocaine injec-
tion (a) is shown according to le-
sion grouping in the left panel,
with the same data grouped ac-
cording to drug treatment in the
right panel. Short-term sensitiza-
tion over the first 5 days of co-
caine injections (growth of post-
injection distance) (b) and pre and
post-injection locomotor distance
in the cocaine challenge session
(c) (to detect long-term sensitiza-
tion) reveal robustly significant
lesion effects. Total rats and sub-
group numbers examined are
same shown in Fig. 1. Data are
depicted as means ± SEMs. All
significant main effects and inter-
actions of the mixed ANOVA are
shown at right with significance
levels denoted as *p < 0.05, **
p < 0.01, and *** p < 0.001
Table 1 RAM-dependent
measures and relationship with
cocaine behavioral sensitization
experiment 1
Variable RAM (FLETR) linear regression with post-cocaine in-
jection locomotion
(n = 40) (n = 40) (N = 80)
SHAM NVHL t Day 1 Day 5 Challenge
FL 4.89 ± 0.32 6.29 ± 0.13 6.6*** R2 = 0.03 R2 = 0.04 R2 = 0.06
NS NS m = 1,346*
b = 9,330**
ETR 5.4 ± 0.09 4.6 ± 0.09 −4.0*** R2 = 0.01 R2 = 0.08 R2 = 0.09
NS m = −4,107* m = −3,874**
b = 40,150*** b = 36,229***
FLETR 0.89 ± 0.06 1.40 ± 0.04 7.1*** R2 = 0.04 R2 = 0.09 R2 = 0.14
NS m = 7,539** m = 8,334***
b = 10,979*** b = 7,310**
Significance levels of simple t tests and linear regressionmodeling (x, RAM variable; y = post-cocaine locomotion
(in centimeter), x = FLETR, m = slope, b = y intercept) are reported as *p < 0.05, **p < 0.01, and ***p < 0.001
with NS denoting non-significance. R2 values reporting goodness of fit, are regarded a significant as per the slope
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pressing in NVHLs (lesion × drug: F(1,8) = 7.70, p < 0.05).
There were no specific interactions between day and NVHL
or NAC on these measures. Non-nicotine-paired lever
responding was very low (Fig. 7d) and did not differ by lesion
or NAC, although some drift in responding, likely spurious in
low responding, was detected (day: F(2,16) = 3.8, p < 0.05).
RAM performance as an estimator of nicotine
self-administration
FLETR trended higher in NVHLs (0.85 ± 0.19) compared
to SHAMs (0.69 ± 0.14), but not significantly. NAC also
did not impact or interact with NVHLs on FLETR. As in
experiment 1, mean FL and ETR were not linearly asso-
ciated (R2 = 0.23, p = NS). There were no significant
linear relationships found between FLETR and total ac-
tive lever pressing in acquisition or extinction. However,
FLETR significantly estimated responding in reinstate-
ment (Fig. 8). Although saline pre-injections did not pro-
duce lever pressing levels linearly estimated by FLETR
(R2 = 0.08, p = NS), pre-injections of nicotine did, in a
dose-dependent way. The significant association between
FLETR and levels of nicotine-induced drug seeking at the
0.25-mg/kg dose (R2 = 0.36, p = 0.04) strengthened at the
0.50-mg/kg dose (R2 = 0.47, p = 0.01). Outlier analyses
removing any one (of n = 12 rats) from the latter linear
regression did not result in a loss of significance. These
significant linear relationships were specific to FLETR;
there were no significant relationships of mean ETR or
mean FL with reinstatement lever pressing.
Fig. 6 Acquisition of nicotine self-administration (experiment 2). Over
15 sessions, rats showed significant growth of bar pressing that (a) deliv-
ered nicotine infusions and (b) time-out responses on the nicotine-paired
lever, with only non-significant differences based on lesion status.
Responding on the non-drug paired (inactive) lever (c) was minimal
and did not evolve over sessions. Data are depicted as means - SEMs.
All significant main effects and interactions of the mixed ANOVA are
shown for each dependent measure (type of lever hit) with significance
levels denoted (** p < 0.01)
Fig. 5 RAM performance as linear estimator of subsequent cocaine
sensitization (experiment 1). Scatter plots show post-cocaine locomotor
activation (y-axis) plotted for each rat as a function of its RAM perfor-
mance calculated as the ratio of mean Froot loops consumed to mean
ETR recorded across the six bins (FLETR; x-axis). Over the entire pop-
ulation (N = 80), R2 values and significance levels of the linear regression
(slope) characterizing a relationship between FLETR and subsequent
cocaine-induced locomotion strengthens with more cocaine injections,
rightward across panels, as the measured locomotor activation levels rep-
resent increasing contributions encoded by the behavioral sensitizing ef-
fects of cocaine. The best fit linear equations for day 5 and challenge day
sessions were y = 7,539x + 10,979, and y = 8,334x + 7,310, where y-
= cocaine-induced locomotion (in centimeter) and x = FLETR
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Discussion
In longitudinal experiments using healthy and NVHL rats, we
characterized how cognitive-behavioral measures of mental
illness severity (on the RAM) may predict subsequent addic-
tion vulnerability, and how medication treatment (with NAC)
initiated in adolescence may alter adult mental illness or ad-
diction phenotypes. The two major findings are: (1) RAM
measures of cognitive-behavioral profiles prior to drug expo-
sure, are linear estimators of subsequent addiction vulnerabil-
ity assessed in long-term cocaine sensitization, and nicotine
self-administration; and (2) NAC has efficacy in reducing
NVHL nicotine seeking after acquisition of nicotine self-ad-
ministration. Although RAM learning, behavioral sensitiza-
tion, and drug self-administration have long served as impor-
tant paradigms for studying cognition and addiction, respec-
tively, these experiments appear to be the first to examine
them longitudinally in the same subjects and to find a
quantitative-association between them. It is likely that
examining both healthy and NVHL rats was important for
defining this association, since NVHL rats provide a more
extreme range of RAM performance (Berg et al. 2014, 2015;
Chambers et al. 1996) and addiction behaviors involving co-
caine and nicotine (Berg and Chambers 2008; Chambers et al.
2013; Chambers and Taylor 2004; Conroy et al. 2007).
There were two noteworthy ways that the associations be-
tween RAM and addiction phenotypes were consistent in ex-
periments 1 and 2, despite using different drugs and behavior-
al paradigms. First, FLETR was a better correlate of subse-
quent addiction vulnerability than either FL or ETR alone.
Second, the correlation of FLETR was best with greater chro-
nicity of drug exposure, in later stages of the addicted pheno-
type, as elicited by drug re-exposure. This convergence sug-
gests that FLTER is picking up on the vulnerability of PFC-
striatal networks, not to the acute effects of cocaine or nico-
tine, but to their capacity to drive long-term neuroadaptations.
Prior studies suggest that this vulnerability is related to struc-
tural and functional abnormalities within frontal-cortical-
Fig. 7 Extinction and reinstatement testing after nicotine self-
administration (experiment 2). Data are plotted according to both lesion
and drug treatment groups given the significant main effects and interac-
tions of both lesion and NAC effects. In extinction on the previously
nicotine-paired (active) lever (a) NAC specifically blunted NVHL in-
creases in drug seeking whereas on the non-nicotine-paired (inactive)
lever (b), there were no lesion differences and responding was low.
Similarly, in reinstatement testing, on the previously nicotine-paired
(active) lever (c), NAC also specifically blunted NVHL increases in drug
seeking with no nicotine-induced responding on the non-nicotine-paired
(inactive) lever (d). Data are depicted as means - SEMs. All significant
main effects and interactions of the mixed ANOVA are shown for each
dependent measure (type of lever hit) with significance levels denoted (*
p < 0.01; **p < 0.01; ***p < 0.001)
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striatal networks that are post-synaptic to dopamine release
and present before repeated drug exposure (Chambers et al.
2010b; Tseng et al. 2009). NVHL rats without chronic drug
histories show abnormal PFC-striatal neuronal activation and
gene expression patterns that are further amplified, particular-
ly within the habit-forming striatum, after exposure to a be-
haviorally sensitizing regimen of cocaine (Chambers et al.
2013, 2010a). Possibly, then, FLETR serves to some extent,
as an Bintegrated network^ measure of addiction vulnerabili-
ty—an estimator of PFC–hippocampal–striatal dysfunction
that sets up addiction risk. It not only quantifies cognition
(i.e., low ETR, reflecting impoverished PFC and hippocampal
structure and function) and reward consumption (i.e., high FL
consumed, related to pathological striatal function), but it
computes a quotient of these variables conveying how dys-
functional one system is in proportion to the other. Hence,
addiction vulnerably in mental illness and/or adolescence
may reflect a mismatch involving deficient PFC cognitive
and inhibitory function with subcortical-striatal hyper-reactiv-
ity to primary and drug reinforcers (Chambers et al. 2001,
2003; Mills et al. 2014). The observation from the larger ex-
periment 1 that FL consumption is elevated in NVHL rats,
while ETR (cognition) is reduced, replicates prior large group
data (Berg et al. 2015) that inspired us to define and analyze
FLETR as a novel RAM measure that may be relevant to
understanding the linkage between mental illness and addic-
tion. High FLETR values in NVHL rats captures two clinical
attributes of schizophrenia patients: over-consumption of car-
bohydrate enriched-foods and cognitive deficits (McCreadie
2003). High FLETR values are also consistent with how
NVHLs show increased natural-reward related impulsivity
and behavioral disinhibition (Chambers et al. 2005;
Chambers and Self 2002; Placek et al. 2013; Tseng et al.
2008) in parallel to PFC-based deficits in decision-making in
schizophrenia patients (Heerey et al. 2008).
We also tested NAC as a treatment that hypothetically cur-
tails abnormal glutamate signaling and/or oxidative injury that
may occur in schizophrenia and/or addiction (Baker et al.
2002; Cabungcal et al. 2014; Lante et al. 2007; Brown et al.
2013; Moran et al. 2005). NAC had little impact on RAM or
NVHL-phenotypes, despite prior indications that the anti-
oxidant properties of NAC may normalize some behavioral
and PFC-physiological abnormalities in NVHL rats
(Cabungcal et al. 2014) and transgenic mice (Otte et al.
2011). However NAC did have a NVHL-specific effect in
reducing nicotine addiction-related behavior, consistent with
several preclinical and human studies (Asevedo et al. 2014;
Carmeli et al. 2012; Grant et al. 2007; Gray et al. 2012;
Knackstedt et al. 2009; Lavoie et al. 2008; Madayag et al.
2007; Moussawi et al. 2009). In particular, the way NAC
suppressed nicotine-seeking after acquiring nicotine self-
administration in NVHL rats, during extinction and reinstate-
ment, are consistent with how NAC disrupts drug-induced
relapse and craving in rats and humans that had already ac-
quired addicted phenotypes (Amen et al. 2011; Ramirez-Nino
et al. 2013; Zhou and Kalivas 2008). The increased seeking
for nicotine observed in the extinction phase in NVHL rats is a
replication (Berg et al. 2014), while the present study is the
first to show increased nicotine seeking in NVHL rats in rein-
statement. Further, this study is the first to show efficacy of a
treatment agent for addiction in an animal model of dual di-
agnosis schizophrenia. NAC’s capacity to reduce expression
Fig. 8 RAM performance as a linear estimator of subsequent nicotine-
seeking (experiment 2). Scatter plots show nicotine-paired (active) lever
pressing during reinstatement sessions (y-axis) plotted for each rat as a
function of its RAM performance calculated as the ratio of mean Froot
loops consumed to mean ETR recorded across the five bins (FLETR; x-
axis). Over the population of rats in the study (n = 12), R2 values and
significance levels of the linear regression (slope) characterizing a rela-
tionship between FLETR and subsequent nicotine-seeking strengthens
rightward across panels, as the relapse-provoking dose of nicotine in-
creases. The best fit linear equations for 0.25 and 0.50-mg nicotine doses
were y = 20.4x + 13.4, and y = 43.8x − 1.7, where y = lever pressing and
x = FLETR
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of the addicted phenotype specifically as it is accentuated in
the NVHL model, supports a common biological basis for
addiction and mental illness at the level of glutamatergic
neurotransmission.
Further studies are needed to address many new questions
that arise from these data such as whether adolescent dosing of
NAC prior to, or during addictive drug exposure optimizes
efficacy, or, whether FLETR on the RAM can also estimate
addiction risk in cocaine self-administration. The use of NAC
at a single dose generates promising lead information for more
adequate pharmacological characterizations of glutamatergic
mechanisms that may link mental illness and addiction. Our
findings provide a parallel to clinical cognitive testing of PFC
function (e.g., Wisconsin Card Sort, Iowa Gambling task,
Delay Discounting) used to quantify severity of both mental
illness and addiction vulnerability (Bechara et al. 1994; Bickel
and Johnson 2003; Weinberger et al. 1985). By suggesting
that a quantifiable estimator of addiction risk may emerge
from a quotient of two variables that measure primitive reward
motivation (striatal circuits) and cognition (PFC–hippocampal
networks; Bahner et al. 2015), the present results suggest the
utility of analogous compound variables in humans to deter-
mine dual diagnosis vulnerability and selectively implement
pharmacological preventions. When paired with functional
neuroimaging approaches (Drobac and Hulvershorn 2014;
Hulvershorn et al. 2013), such testing in adolescents and
young adults could inform clinical decision-making on novel
treatments that reduce addictions in the most vulnerable
patients.
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